MedTrace Logo

Primary Infection Cohort

NCT03148964 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2800

Last updated 2022-10-19

No results posted yet for this study

Summary

Open, prospective, multicenter French cohort study enrolling subjects aged of 15 years or more, during or immediately after HIV-1 primary infection. This cohort was organized from the outset to be highly multidisciplinary, bringing together immunologists, virologists, clinicians and epidemiologists.

Conditions

Interventions

BIOLOGICAL

blood sampling

Blood Sampling at J0, M1, M3, M6, M12, M24 and every 12 months until the end of the study

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Laurence Meyer, Professor · CESP-INSERM U1018

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-10-31
Primary Completion
2024-09-30
Completion
2025-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03148964 on ClinicalTrials.gov